Avatrombopag maleate is a pharmaceutical compound developed for the treatment of thrombocytopenia, a condition characterized by abnormally low levels of platelets in the blood. This medication is primarily used to boost platelet counts in certain patient populations.

Here's a general product description for Avatrombopag maleate:

1. Chemical Name: Avatrombopag maleate
2. Chemical Formula: The specific chemical formula would be determined by the molecular structure of Avatrombopag maleate.
3. Appearance: Avatrombopag maleate may exist as a white to off-white crystalline powder.
4. Pharmacological Action: Avatrombopag is a thrombopoietin receptor agonist. It works by stimulating the production and maturation of platelets in the bone marrow, thereby increasing platelet counts in the blood.
5. Medical Uses: It is indicated for the treatment of thrombocytopenia in patients with chronic liver disease who are scheduled to undergo a medical or dental procedure to reduce the risk of bleeding.
6. Dosage Form: Avatrombopag maleate may be available in tablet form for oral administration.
7. Dosage and Administration: Specific dosage recommendations and administration instructions are determined based on clinical trial data and regulatory guidelines. The dosage and treatment duration might vary depending on individual patient factors and the specific condition being treated.
8. Safety and Precautions: Information regarding safety, potential side effects, contraindications, and precautions would be provided based on clinical trial findings and research data. Monitoring of liver function and blood counts might be recommended during treatment.